Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood test
MedTech
Natera buys Foresight Diagnostics in $450M cancer testing deal
Natera has closed the transaction, which features an upfront payment of $275 million plus as much as $175 million in milestones.
Conor Hale
Dec 5, 2025 11:57am
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
FDA approves next-gen PSA test from Cleveland Diagnostics
Dec 3, 2025 10:05am
Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission
Nov 13, 2025 9:05am
Guardant blood test gives early warning of cancer progression
Nov 10, 2025 8:15am
Labcorp to carry Roche's FDA-cleared Alzheimer's blood test
Oct 24, 2025 8:45am
